Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | JUN | P05412 | 1/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.35 |
| ▸ | P2RX3 | P56373 | 4/20 | 0.35 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | RORC | P51449 | 1/20 | 0.33 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.33 |
| ▸ | ELANE | P08246 | 1/20 | 0.33 |
| ▸ | MDM2 | Q00987 | 2/20 | 0.33 |
| ▸ | ERN1 | O75460 | 1/20 | 0.33 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.33 |
| ▸ | ACACB | O00763 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6578342 | 0.92 | ALDH1A1 (0.39) | ALDH1A1KMT2APARP10MDM2ERN1 | |
| SCHEMBL6935704 | 0.83 | ALDH1A1 (0.41) | ALDH1A1JUNNFKB1P2RX3IRAK4 | |
| SCHEMBL3688114 | 0.78 | XDH (0.40) | ALDH1A1P2RX3IRAK4KMT2ARORC | |
| SCHEMBL16309558 | 0.77 | JUN (0.45) | ALDH1A1JUNNFKB1KMT2AERN1 | |
| SCHEMBL3682833 | 0.75 | KMT2A (0.53) | ALDH1A1KMT2APARP10ELANEACACB | |
| SCHEMBL340676 | 0.75 | TSHR (0.43) | ALDH1A1KMT2APARP10ELANE | |
| SCHEMBL16957470 | 0.74 | MEN1 (0.40) | P2RX3KMT2AAKR1C3ACACB | |
| SCHEMBL31372250 | 0.74 | KMT2A (0.49) | ALDH1A1KMT2A | |
| SCHEMBL18360184 | 0.74 | KMT2A (0.49) | ALDH1A1KMT2A | |
| SCHEMBL339283 | 0.74 | ALDH1A1 (0.49) | ALDH1A1KMT2ARORC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10584141-B2 | Recyclable metathesis catalysts | THE TRUSTEES OF BOSTON COLLEGE (US) | 2020-03-10 | — | — | US | disclosed |
| US-20190309001-A1 | RECYCLABLE METATHESIS CATALYSTS | THE TRUSTEES OF BOSTON COLLEGE | 2019-10-10 | — | — | US | disclosed |
| US-10336781-B2 | Recyclable metathesis catalysts | THE TRUSTEES OF BOSTON COLLEGE (US) | 2019-07-02 | — | — | US | disclosed |
| US-20160168181-A1 | RECYCLABLE METATHESIS CATALYSTS | THE TRUSTEES OF BOSTON COLLEGE | 2016-06-16 | — | — | US | disclosed |
| EP-1313559-B2 | RECYCLABLE METATHESIS CATALYSTS | TRUSTEES BOSTON COLLEGE (US) | 2012-10-24 | — | — | EP | disclosed |
| US-20100292486-A1 | RECYCLABLE METATHESIS CATALYSTS | HOVEYDA AMIR H | 2010-11-18 | — | — | US | disclosed |
| US-7723255-B2 | Recyclable metathesis catalysts | THE TRUSTEES OF BOSTON COLLEGE (US) | 2010-05-25 | — | — | US | disclosed |
| EP-1313559-B1 | RECYCLABLE METATHESIS CATALYSTS | TRUSTEES BOSTON COLLEGE (US) | 2009-11-11 | — | — | EP | disclosed |
| US-20050272598-A1 | Recyclable metathesis catalysts | THE TRUSTEES OF BOSTON COLLEGE | 2005-12-08 | — | — | US | disclosed |
| US-6921735-B2 | Recyclable metathesis catalysts | THE TRUSTEES OF BOSTON COLLEGE (US) | 2005-07-26 | — | — | US | disclosed |
| EP-1313559-A4 | RECYCLABLE METATHESIS CATALYSTS | TRUSTEES BOSTON COLLEGE (US) | 2004-02-04 | — | — | EP | disclosed |
| EP-1313559-A2 | RECYCLABLE METATHESIS CATALYSTS | Trustees of Boston College (US) | 2003-05-28 | — | — | EP | disclosed |
| US-20020107138-A1 | Recyclable metathesis catalysts | NATIONAL SCIENCE FOUNDATION | 2002-08-08 | — | — | US | disclosed |
| WO-2002014376-A2 | RECYCLABLE METATHESIS CATALYSTS | TRUSTEES OF BOSTON COLLEGE (US) | 2002-02-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190309001-A1 | RECYCLABLE METATHESIS CATALYSTS | DNMT1, CARM1, ZMYND8 | ALDH1A1 2343/4885JUN 1173/4885NFKB1 3970/4885 |
| US-20100292486-A1 | RECYCLABLE METATHESIS CATALYSTS | DNMT1, CARM1, ZMYND8 | ALDH1A1 2343/4885JUN 1173/4885NFKB1 3970/4885 |
| US-10584141-B2 | Recyclable metathesis catalysts | DNMT1, CARM1, ZMYND8 | ALDH1A1 2343/4885JUN 1173/4885NFKB1 3970/4885 |
| US-10336781-B2 | Recyclable metathesis catalysts | DNMT1, CARM1, ZMYND8 | ALDH1A1 2343/4885JUN 1173/4885NFKB1 3970/4885 |
| US-20160168181-A1 | RECYCLABLE METATHESIS CATALYSTS | DNMT1, CARM1, ZMYND8 | ALDH1A1 2343/4885JUN 1173/4885NFKB1 3970/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.